CAPS2-AS1

Across TCGA pan-cancer cohorts, CAPS2-AS1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CAPS2-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where CAPS2-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types CAPS2-AS1 is over-expressed in tumor, although a few such as THCA and LUAD show the opposite, repressed pattern.

THCA, KICH, and LUAD are the cancer types where CAPS2-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CAPS2-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.033	<.001	5	view →
KICH	All	All	+0.020	.036	2	view →
LUAD	Female	II,III,IV	−0.044	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CAPS2-AS1–THCA

Open the THCA breakdown →